SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS: RANDOMIZED TRIAL - Trial NCT06392633
Access comprehensive clinical trial information for NCT06392633 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental and is currently Recruiting. The study focuses on Stroke. Target enrollment is 44 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Timeline & Enrollment
N/A
Jan 01, 2021
Dec 01, 2024
Primary Outcome
Quality of life by 36-Item Short Form Survey Instrument (SF-36),Quality of life by Newcastle Stroke-Specific Quality of Life Measure
Summary
We present a research project in the form of a controlled clinical trial with the aim of
 analyzing and demonstrating whether the surgical treatment of upper limb spasticity is an
 effective and efficient measure to improve dependence and quality of life perceived by
 patients with sequelae of stroke and therefore, should be included in the therapeutic
 protocols, in which it is not usually contemplated, as a complement or alternative to
 traditional treatment with botulinum toxin, rehabilitation and occupational therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06392633
Non-Device Trial